Skip to Content
Merck
CN

IF02L

Anti-Desmin (Ab-1) Mouse mAb (DE-B-5)

lyophilized, clone DE-B-5, Calbiochem®

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352203
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

mouse

Quality Level

antibody product type

primary antibodies

clone

DE-B-5, monoclonal

form

lyophilized

does not contain

preservative

species reactivity

human

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

isotype

IgG1

shipped in

ambient

storage temp.

2-8°C

General description

Purified mouse monoclonal antibody generated by immunizing mice with the specified immunogent and fusing splenocytes with PAI mouse myeloma cells (see application references). Recognizes the ~53 kDa Desmin protein.

This product has been discontinued.



Recognizes the ~53 kDa Desmin protein in muscle cells and tissue. Does not cross-react with other classes of intermediate filaments.

Immunogen

Human

Application

Frozen Sections (1-5 µg/ml, see application references)

Immunoblotting (1-5 µg/ml, see application references)

Immunocytochemistry (1-5 µg/ml, see application references)

Paraffin Sections (1-10 µg/ml, heat pre-treatment required, see application references)

Physical form

Lyophilized from 20 mM NH₄HCO₃, 100 µg BSA.

Preparation Note

We recommend resuspending the lyophilized antibody with sterile phosphate buffered saline (PBS), pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least 2 h. Avoid freeze/thaw cycles. Antibody should be titrated for optimal results in individual systems.

Analysis Note

Negative Control
Epithelial cells or tissue
Positive Control
Muscle cells or tissue

Other Notes

Debus, E., et al. 1983. EMBO J.2, 2305.
Geisler, N., et al. 1982. Cell30, 277.
Lazarides, E. 1982. Ann. Rev. Biochem.51, 219.
Osborn, M. and Weber, K., 1982. Cell31, 303.
This antibody stains intermediate filaments found in skeletal, visceral and vascular smooth muscle cells, as well as those found in certain established cell lines such as the human rhabdomyosarcoma line (see application references). Desmin is also found in rhabdomyosarcoma biopsies, and is positively stained in smaller, round cells, which are difficult to judge histologically as rhabdomyosarcoma. Does not recognize other classes of intermediate filament proteins (see application references). Antibody should be titrated for optimal results in individual systems.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)


Still not finding the right product?

Try our Product Selector Tool to narrow your options


Storage Class

10-13 - German Storage Class 10 to 13

Regulatory Information

新产品

This item has



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Stefania Senger et al.
PloS one, 10(12), e0144634-e0144634 (2015-12-10)
In celiac disease (CD), intestinal epithelium damage occurs secondary to an immune insult and is characterized by blunting of the villi and crypt hyperplasia. Similarities between Hedgehog (Hh)/BMP4 downregulation, as reported in a mouse model, and CD histopathology, suggest mechanistic
Lingling Xu et al.
Cell reports, 41(8), 111709-111709 (2022-11-24)
The function of fibroblasts in intracerebral hemorrhage (ICH) remains elusive. By targeting Col1α1, a fibroblast-specific marker, we generate mice with ablated Col1α1+ fibroblasts. These mutants show exacerbated blood-brain barrier (BBB) damage, enlarged injury volume, and worse neurological function, highlighting a